Define Ventures
Overview
Define Ventures is a venture capital firm that focuses exclusively on early-stage digital-health startups at the incubation, seed, series A, and series B stages.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cohere Health | May 2025 | Series C | Co-investor |
| Tia | Sep 2021 | Series B | Co-investor |
| Hyro | Oct 2025 | Growth Equity | Co-investor |
| 9amHealth | May 2026 | Series B | Lead |
| Luminai | Apr 2026 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Define Ventures based?
Define Ventures is headquartered in San Francisco, California, United States.
When was Define Ventures founded?
Define Ventures was founded in 2019.
How many portfolio companies does Define Ventures have?
Define Ventures has 10 portfolio companies in Caplight's dataset.
What are some companies in Define Ventures's portfolio?
Portfolio companies visible on Caplight include Cohere Health, Tia, Hyro, 9amHealth, Luminai.
What was Define Ventures's most recent investment shown here?
Define Ventures's most recent investment in this portfolio sample was in 9amHealth in 2026.
What sectors does Define Ventures focus on?
Define Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Enterprise Software.
What company stages does Define Ventures focus on?
Define Ventures typically invests at the MultiStage stage.
What is Define Ventures's AUM?
Define Ventures's assets under management are estimated between $800.0M and $800.0M.